Skip to content

Implementation research on the intervention mode of "Comorbidity—Co-causes—Joint-prevention" comprehensive demonstration district of depression and obesity among children and adolescents in Beijing

Implementation research on the intervention mode of "Comorbidity—Co-causes—Joint-prevention" comprehensive demonstration district of depression and obesity among children and adolescents in Beijing

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087514
Enrollment
Unknown
Registered
2024-07-29
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression and obesity comorbidities

Interventions

intervention for phase I:Screening was performed without intervention for those enrolled in phase I. The samples of the intervention and control groups were derived from a phase of screening.
intervention group for phase ?:combination intervention strategy of " Comorbidity—Co-causes—Joint-prevention"
intervention control group for phase ?:routine health education and mental health knowledge

Sponsors

Beijing Anding Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Phase I: 1.Middle school students in Jingkai District and other districts of Beijing, both boys and girls; 2.Students themselves and their guardians are willing to participate in this study and sign written informed consent file. Phase ?: Middle school students who were screened at high risk of depression and/or obesity in Jingkai District and other districts of Beijing, the screening criteria are as follows: ? CES-DC score>=16 points; ? BMI>=WS/T586-2018: Screening for overweight and obesity among school-age children and adolescents, recommended by the National Health Commission; ? Students themselves and their guardians are willing to participate in this study and sign written informed consent file.

Exclusion criteria

Exclusion criteria: Phase I: 1.Having serious physical or genetic disease that is not suitable for participation in the study; 2.Have been evaluated that not suitable for this study by investigators. Phase ?: 1.Having serious physical or genetic disease that is not suitable for participation in the study; 2.Have been evaluated that not suitable for this study by investigators.

Design outcomes

Primary

MeasureTime frame
Patient Health Questionnaire-9;

Countries

China

Contacts

Public ContactLinghui Meng

Beijing Anding Hospital, Capital Medical University

linghuimeng@mail.ccmu.edu.cn+86 186 0119 7807

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026